Gómez-Santacana, Xavier;
de Munnik, Sabrina M;
Mocking, Tamara A M;
Hauwert, Niels J;
Sun, Shanliang;
Vijayachandran, Prashanna;
de Esch, Iwan J P;
Vischer, Henry F;
Wijtmans, Maikel;
Leurs, Rob
A toolbox of molecular photoswitches to modulate the CXCR3 chemokine receptor with light
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
A toolbox of molecular photoswitches to modulate the CXCR3 chemokine receptor with light
Beteiligte:
Gómez-Santacana, Xavier;
de Munnik, Sabrina M;
Mocking, Tamara A M;
Hauwert, Niels J;
Sun, Shanliang;
Vijayachandran, Prashanna;
de Esch, Iwan J P;
Vischer, Henry F;
Wijtmans, Maikel;
Leurs, Rob
Erschienen:
Beilstein Institut, 2019
Erschienen in:Beilstein Journal of Organic Chemistry
Beschreibung:
<jats:p>We report a detailed structure–activity relationship for the scaffold of VUF16216, a compound we have previously communicated as a small-molecule efficacy photoswitch for the peptidergic chemokine GPCR CXCR3. A series of photoswitchable azobenzene ligands was prepared through various synthetic strategies and multistep syntheses. Photochemical and pharmacological properties were used to guide the design iterations. Investigations of positional and substituent effects reveal that halogen substituents on the <jats:italic>ortho</jats:italic>-position of the outer ring are preferred for conferring partial agonism on the <jats:italic>cis</jats:italic> form of the ligands. This effect could be expanded by an electron-donating group on the <jats:italic>para</jats:italic>-position of the central ring. A variety of efficacy differences between the <jats:italic>trans</jats:italic> and <jats:italic>cis</jats:italic> forms emerges from these compounds. Tool compounds VUF15888 (<jats:bold>4d</jats:bold>) and VUF16620 (<jats:bold>6e</jats:bold>) represent more subtle efficacy switches, while VUF16216 (<jats:bold>6f</jats:bold>) displays the largest efficacy switch, from antagonism to full agonism. The compound class disclosed here can aid in new photopharmacology studies of CXCR3 signaling.</jats:p>